Pcas SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other
pharmaceutical manufacturers in Europe:
Vectura Group PLC
of the United Kingdom
sales of £148.00 million [US$194.74 million]
of which 100%
was Pharmaceutical Prod),
(257.63 million Euro [US$300.97 million]
of which 83%
was EVT Execute), and
Laboratorio Reig Jofre SA
based in Spain
(167.98 million Euro [US$196.24 million]
of which 85%
was Sale of Pharmaceutical Products).
During the year ended December of 2017, sales at
Pcas SA were 218.27 million Euro (US$254.99 million).
increase of 13.7%
versus 2016, when the company's sales were 191.99 million Euro.
This was the fourth straight year of sales growth at Pcas SA.
Sales of Pharmaceutical Synthesis saw an increase
14.6% in 2017, from
129.97 million Euro to 148.94 million Euro.